SCHEMBL1700701

SCHEMBL1700701

CC(=O)N1CCC(Nc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])C1

nearest known ligand 0.89

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ BCL2 P10415 19/20 0.89

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1700693 1.00 BCL2 (0.89) BCL2
SCHEMBL30314026 1.00 BCL2 (0.89) BCL2
SCHEMBL29657419 0.97 BCL2 (0.89) BCL2
SCHEMBL1701503 0.97 BCL2 (0.89) BCL2
SCHEMBL30467991 0.95 BCL2 (0.86) BCL2
SCHEMBL1701702 0.95 BCL2 (0.86) BCL2
SCHEMBL30313881 0.94 BCL2 (1.00) BCL2
SCHEMBL30314224 0.94 BCL2 (1.00) BCL2
SCHEMBL1699824 0.94 BCL2 (1.00) BCL2
SCHEMBL1699792 0.94 BCL2 (1.00) BCL2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2576546-A1 APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES Abbvie Inc. (US) 2013-04-10 — — EP disclosed
WO-2011149492-A1 APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES ABBOTT LABORATORIES (US) 2011-12-01 — — WO disclosed
Send feedback